Els Torreele Named Executive Director Of Global MSF Access Campaign 08/12/2016 by William New, Intellectual Property Watch 2 Comments Veteran public health advocate Els Torreele of Belgium has been named the new executive director of the high-profile Médecins Sans Frontières (MSF, Doctors Without Borders) Access Campaign, based in Geneva.
Support IP-Watch: An Appeal To Readers 06/12/2016 by Intellectual Property Watch, Intellectual Property Watch 2 Comments Intellectual Property Watch needs your financial support. As one of our readers, you know that IP-Watch plays a vital role in international policymaking on intellectual property and innovation through its independent, reliable, balanced and dedicated news coverage. But like other online news services around the world, the challenges of financial sustainability are high. Please help […]
Thomas Cueni Of Switzerland Named Director General Of IFPMA 02/12/2016 by William New, Intellectual Property Watch Leave a Comment Thomas Cueni of Switzerland has been named the next director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the Geneva-based organisation which represents the global research-based pharma industry.
Helping Patenters In A Sea Of PAEs: Interview With LOT Network’s Ken Seddon 01/12/2016 by William New, Intellectual Property Watch 1 Comment Patent assertion entity (PAE) activity has skyrocketed in the past decade and much discussion has occurred around what to do in response to patent holders whose strategy is more focused on legal battles than innovating. One notable group has risen up to bring together global companies to address the PAE issue with a novel sharing approach. In an interview with Intellectual Property Watch, Ken Seddon, CEO and President of LOT Network, talks about the group’s rapid growth, what’s coming next, and how not to bring a squirt gun to a nuclear fight.
Pfizer CEO Ian Read Elected To Rotating IFPMA Presidency 30/11/2016 by Intellectual Property Watch Leave a Comment Pfizer Board Chairman and CEO Ian Read has been elected as the next president of the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), a two-year role.
Hundreds Of Civil Society Groups Urge RCEP Negotiators To Reject Imported TPP Clauses 30/11/2016 by Intellectual Property Watch Leave a Comment As 16 Asia and Pacific nations prepare to meet in Indonesia next week for the next round of negotiations for a large regional trade agreement called RCEP, more than 300 civil society groups signed a letter urging negotiators to reject efforts to bring in texts from the separate Trans-Pacific Partnership (TPP).
Kenya: Collective Management Organisations In Danger After Court Questions Their Role 28/11/2016 by Maina Waruru for Intellectual Property Watch Leave a Comment NAIROBI, Kenya — A ruling this month by a Kenyan court that artists, performers and musicians cannot be compelled or forced to join a collective management organisation (CMO) to collect royalties on their behalf could spell doom for CMOs in the country, experts fear.
Eduardo Pisani To Step Down From IFPMA’s Helm In January 23/11/2016 by Catherine Saez, Intellectual Property Watch 31 Comments The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that its director general is stepping down at the end of January.
Resale Royalty Right: A Way To Redress Imbalance In Copyright Revenue, WIPO Told 22/11/2016 by Catherine Saez, Intellectual Property Watch 1 Comment When visual artists sell their work, they usually perceive a price for that work. If it is resold at a much higher price, some countries provide for a resale right, providing artists with resale royalties. In other countries, such a right does not exist, putting visual artists in a disadvantageous situation, particularly indigenous artists, whose work can become very valuable on the international art markets.
What’s Coming On IP For The US, Geneva? An Interview With Q. Todd Dickinson 21/11/2016 by William New, Intellectual Property Watch 1 Comment Q. Todd Dickinson is a shareholder at Polsinelli law firm, and was director of the United States Patent and Trademark Office (USPTO) under President Clinton, a former lead IP counsel for two Fortune 50 corporations, and most recently executive director of the American Intellectual Property Law Association (AIPLA). In an interview with Intellectual Property Watch on 18 November in the margins of the IP Dealmakers conference in New York, Dickinson discussed US prospects for national and international IP policy after the presidential election, changes in Geneva, reform of US IP law, and repairing relationships.